Interestingly, in HER2 amplified breast cancer cells, inhibition of HER2 increased TRAIL receptor agonist mediated apoptosis and mechanistically this was primarily due to the inhibition of AKT signaling [167] suggesting that the effects of EGFR inhibition may be similar. This evidence concerns the gene ERBB2 and breast carcinoma.